Univest
Univest
  • Markets

HCLTech Share Price Falls Over 2 Percent on 14 July 2026 as CLSA and Citi Cut Ratings and Targets After Q1 FY27 Results

  • July 14, 2026
  • Posted by: Neeraj Pandey
  • Category: News
No Comments
HCLTech Share Price

HCLTech share price Rs 1,193.70, down 2.25%. CLSA cuts to Hold, target Rs 1,202. Citi cuts to Sell, target Rs 1,040. Day range Rs 1,182.60 to Rs 1,209.10.

The HCLTech share price fell more than 2 percent in trade on 14 July 2026 after two global brokerages, CLSA and Citi, cut their ratings and price targets on the IT services major following its Q1 FY27 earnings. The stock was quoting around Rs 1,193.70, down Rs 27.50 or 2.25 percent, as of 10:31 AM, after opening at Rs 1,200 and touching an intraday high of Rs 1,209.10 and a low of Rs 1,182.60.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • CLSA Downgrades HCLTech to Hold, Target Rs 1,202
  • Citi Downgrades HCLTech to Sell, Target Cut to Rs 1,040
  • HCLTech Stock Performance and Key Levels
  • What This Means for Investors
  • Conclusion
  • Frequently Asked Questions
    • Why did the HCLTech share price fall on 14 July 2026?
    • What is CLSA’s rating and target price on HCLTech?
    • What is Citi’s rating and target price on HCLTech?
    • What was the HCLTech share price today?
    • How was HCLTech’s Q1 FY27 performance according to brokerages?
    • What is the 52 week range of HCLTech shares?
    • Should I buy HCLTech shares after these downgrades?

CLSA Downgrades HCLTech to Hold, Target Rs 1,202

CLSA downgraded HCLTech to a Hold rating from Outperform earlier, setting a price target of Rs 1,202. The brokerage noted that the March quarter was decent, with better than feared revenue growth and strong deal wins, along with a strong AI narrative built around increased revenue per employee. CLSA also flagged the company’s datacentre investment as an opportunity to offer full stack AI solutions and highlighted a large small language model opportunity for HCLTech’s Services Integration and Support business globally in the current high token cost environment.

Importantly, CLSA said there was no change in HCLTech’s FY27 constant currency organic revenue growth guidance, though it forecast 2.7 percent organic constant currency growth for FY27, lower than what it expects from larger peer TCS. The brokerage believes that at the current 15 percent valuation premium to TCS, the HCLTech share price is fairly valued rather than undervalued, which is the key reason behind the rating downgrade.

Citi Downgrades HCLTech to Sell, Target Cut to Rs 1,040

Citi went further, downgrading HCLTech to a Sell rating and cutting its price target sharply to Rs 1,040. The brokerage described the Q1 print as in-line with guidance left unchanged, but flagged that slowing growth combined with a weaker software business makes the stock’s roughly 20 percent valuation premium to Infosys and TCS look stretched. Citi lowered its FY27 and FY28 earnings per share estimates for HCLTech by 1 to 3 percent to reflect this.

On the positive side, Citi acknowledged that HCLTech announced an AI data centre plan with a potential capacity of 50 megawatts, but flagged that key risks to its bearish view include the possibility of better than expected industry growth, market share gains, and margin expansion going forward. Together, the two downgrades pressured the HCLTech share price lower in an otherwise mixed session for IT stocks.

HCLTech Stock Performance and Key Levels

Metric Value
HCLTech CMP (10:31 AM) Rs 1,193.70
Day Change -2.25%
Day Range Rs 1,182.60 – Rs 1,209.10
Previous Close Rs 1,221.20
52 Week Range Rs 1,030.00 – Rs 1,780.10
CLSA Target (Hold) Rs 1,202
Citi Target (Sell) Rs 1,040

Check SEBI Registered Investment Advisor Research on Univest

At the current market price, the HCLTech share price is trading well below its 52 week high of Rs 1,780.10, which highlights how much the stock has corrected over the past year as IT services demand has remained patchy. With Citi’s revised target of Rs 1,040 sitting below the current market price, and CLSA’s Rs 1,202 target offering only limited near term upside, most brokerage commentary released today points to a cautious near term stance on the stock.

What This Means for Investors

The contrasting brokerage actions on HCLTech, one shifting to a neutral Hold and the other turning outright bearish with a Sell call, underline how divided the street currently is on the pace of the company’s AI led revenue acceleration versus the drag from its slower growing software segment. Investors tracking the HCLTech share price should watch how the stock’s premium to TCS and Infosys evolves over the coming quarters, since both CLSA and Citi flagged valuation as the central concern behind their downgrades rather than any deterioration in near term execution.

Conclusion

The HCLTech share price corrected sharply on 14 July 2026 after CLSA and Citi both trimmed their ratings following Q1 FY27 results, even as the company’s revenue growth and deal wins came in ahead of muted expectations. With price targets now ranging from Rs 1,040 to Rs 1,202 across brokerages, investors should track upcoming commentary on the company’s AI data centre plans and constant currency growth trajectory before making fresh allocation decisions.

Download the Univest iOS App or Univest Android App to track HCLTech share price live along with the latest brokerage ratings.

Frequently Asked Questions

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Why did the HCLTech share price fall on 14 July 2026?

Ans. The HCLTech share price fell after CLSA downgraded the stock to Hold with a Rs 1,202 target and Citi downgraded it further to Sell with a target cut to Rs 1,040, both citing valuation concerns following the company’s Q1 FY27 results.

What is CLSA’s rating and target price on HCLTech?

Ans. CLSA cut its rating on HCLTech to Hold from Outperform earlier and set a price target of Rs 1,202, noting that at a 15 percent premium to TCS the stock looks fairly valued rather than a fresh buying opportunity.

What is Citi’s rating and target price on HCLTech?

Ans. Citi downgraded HCLTech to Sell and cut its price target to Rs 1,040, flagging slowing growth and a weaker software business against a roughly 20 percent valuation premium to Infosys and TCS.

What was the HCLTech share price today?

Ans. HCLTech was quoting around Rs 1,193.70, down about 2.25 percent, as of 10:31 AM on 14 July 2026, after touching an intraday high of Rs 1,209.10 and a low of Rs 1,182.60.

How was HCLTech’s Q1 FY27 performance according to brokerages?

Ans. Both CLSA and Citi described HCLTech’s Q1 FY27 print as broadly in line to slightly better than feared, with decent revenue growth and strong deal wins, and management kept its FY27 constant currency organic revenue growth guidance unchanged.

What is the 52 week range of HCLTech shares?

Ans. HCLTech has traded between a 52 week low of Rs 1,030.00 and a 52 week high of Rs 1,780.10, and the stock is currently well below the upper end of that range after the latest round of brokerage downgrades.

Should I buy HCLTech shares after these downgrades?

Ans. Given the mixed brokerage views ranging from Hold to Sell, investors should consult a SEBI-registered advisor and review HCLTech’s constant currency growth trajectory, AI data centre plans and software segment performance before making any investment decision.



News Share Price Falling
Author: Neeraj Pandey
Neeraj Pandey is a Financial Content Writer at Univest, covering Indian equity markets with a specialisation in quarterly earnings previews and analyst consensus analysis. His published work tracks Q4 FY26 results across 10+ sectors — from IT heavyweights like Infosys and TCS to PSUs like Coal India and Balmer Lawrie, and mid-caps like Neuland Laboratories, MCX, and Whirlpool of India. His writing approach is data-first: every article anchors on NSE/BSE filings, analyst consensus estimates (revenue, PAT, EBITDA margins), 52-week price context, and YoY/QoQ comparisons — giving retail investors the same structured framework institutional desks use before an earnings event. He combines SEO-optimised structure with rigorous data sourcing, ensuring each preview ranks for investor search intent while meeting SEBI editorial standards. All articles are reviewed by Univest's in-house equity research team, led by Ankit Jaiswal, Senior Equity Research Analyst, to meet SEBI editorial standards.

Leave a Reply Cancel reply